338 related articles for article (PubMed ID: 16901303)
1. Management of basal cell carcinoma by surveyed dermatologists in Scotland.
Gudi V; Ormerod AD; Dawn G; Green C; MacKie RM; Douglas WS; Gupta G;
Clin Exp Dermatol; 2006 Sep; 31(5):648-52. PubMed ID: 16901303
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of basal cell carcinomas: an audit of current practice.
Mc Loone NM; Tolland J; Walsh M; Dolan OM
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):698-701. PubMed ID: 16836498
[TBL] [Abstract][Full Text] [Related]
3. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation.
Rodriguez-Vigil T; Vázquez-López F; Perez-Oliva N
J Am Acad Dermatol; 2007 Jan; 56(1):91-5. PubMed ID: 17190625
[TBL] [Abstract][Full Text] [Related]
4. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
Hansen C; Wilkinson D; Hansen M; Soyer HP
Arch Dermatol; 2009 Nov; 145(11):1253-60. PubMed ID: 19917954
[TBL] [Abstract][Full Text] [Related]
5. Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions.
Boulinguez S; Grison-Tabone C; Lamant L; Valmary S; Viraben R; Bonnetblanc JM; Bédane C
Br J Dermatol; 2004 Sep; 151(3):623-6. PubMed ID: 15377349
[TBL] [Abstract][Full Text] [Related]
6. Preoperative assessment of basal cell carcinoma using conventional fluorescence diagnosis.
Neus S; Gambichler T; Bechara FG; Wöhl S; Lehmann P
Arch Dermatol Res; 2009 Apr; 301(4):289-94. PubMed ID: 18979108
[TBL] [Abstract][Full Text] [Related]
7. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes.
McCormack CJ; Kelly JW; Dorevitch AP
Arch Dermatol; 1997 May; 133(5):593-6. PubMed ID: 9158412
[TBL] [Abstract][Full Text] [Related]
8. Basal cell carcinoma on the trunk is associated with excessive sun exposure.
Neale RE; Davis M; Pandeya N; Whiteman DC; Green AC
J Am Acad Dermatol; 2007 Mar; 56(3):380-6. PubMed ID: 17097387
[TBL] [Abstract][Full Text] [Related]
9. The management of basal cell carcinomas.
Barry J; Oon SF; Watson R; Barnes L
Ir Med J; 2006 Jun; 99(6):179-81. PubMed ID: 16921825
[TBL] [Abstract][Full Text] [Related]
10. Difficult to diagnose skin cancer--the 'aggressive' BCC.
Tomas S
Aust Fam Physician; 2009 Jul; 38(7):492-7. PubMed ID: 19575067
[TBL] [Abstract][Full Text] [Related]
11. Excising basal cell carcinoma in general practice.
Bostock-Ling N
Aust Fam Physician; 2006 Jul; 35(7):558-60. PubMed ID: 16820836
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of aminolaevulinic acid and methylaminolaevulinate in basal cell carcinomas: a perfusion study using microdialysis in vivo.
Sandberg C; Halldin CB; Ericson MB; Larkö O; Krogstad AL; Wennberg AM
Br J Dermatol; 2008 Nov; 159(5):1170-6. PubMed ID: 18717673
[TBL] [Abstract][Full Text] [Related]
13. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
[TBL] [Abstract][Full Text] [Related]
14. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinomas and actinic keratoses seen in dermatological practice in France: a cross-sectional survey.
Bernard P; Dupuy A; Sasco A; Brun P; Duru G; Nicoloyannis N; Grob JJ
Dermatology; 2008; 216(3):194-9. PubMed ID: 18182809
[TBL] [Abstract][Full Text] [Related]
16. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
Lawrence CM; Haniffa M; Dahl MG
Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
[TBL] [Abstract][Full Text] [Related]
17. A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma.
McKenna DB; Marioni JC; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Sep; 151(3):636-44. PubMed ID: 15377351
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of basal cell carcinoma patients by dermatologists in Netherland].
Thissen MR; Neumann HA; Berretty PJ; Ideler AH
Ned Tijdschr Geneeskd; 1998 Jul; 142(27):1563-7. PubMed ID: 9763832
[TBL] [Abstract][Full Text] [Related]
19. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
Hamada S; Kersey T; Thaller VT
Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
[TBL] [Abstract][Full Text] [Related]
20. Treatment of basal cell carcinomas by general practitioners in Australia.
Streeton CL; Gospodarevskaya E; Harris A
Int J Dermatol; 2006 Apr; 45(4):345-51. PubMed ID: 16650155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
